Schädelin J, Schilt H U, Rohner M
Medizinische Universitatsklinik Inselspital, Bern, Switzerland.
Am J Med. 1988 Aug 29;85(2A):46-8.
Acyclovir was shown to limit herpes simplex reactivation in a controlled trial to prevent herpes labialis after surgical intervention for trigeminal neuralgia. Of 14 patients receiving acyclovir, unambiguous herpes labialis developed in only one, compared with 12 of 16 in the placebo group.
在一项对照试验中，阿昔洛韦被证明可限制单纯疱疹病毒的再激活，以预防三叉神经痛手术干预后的唇疱疹。在接受阿昔洛韦治疗的14名患者中，只有1人出现明确的唇疱疹，而安慰剂组16人中有12人出现唇疱疹。
